|
[1]
|
Mcdermott, M.F., Aksentijevich, I., Galon, J., et al. (1999) Germline Mutations in the Extracellular Domains of the 55 kDa TNF Receptor, TNFR1, Define a Family of Dominantly Inherited Autoinflammatory Syndromes. Cell, 97, 133-144. [Google Scholar] [CrossRef]
|
|
[2]
|
Mcgonagle, D. and Mcdermott, M.F. (2006) A Proposed Classification of the Immunological Diseases. PLOS Medicine, 3, e297. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
高思豪, 宋红梅. 快速进展的自身炎症性疾病[J]. 罕见病研究, 2022, 1(3): 238-244.
|
|
[4]
|
Ben-Chetrit, E., Gattorno, M., Gul, A., et al. (2018) Consensus Proposal for Taxonomy and Definition of the Autoinflammatory Diseases (AIDs): A Delphi Study. Annals of Rheumatic Diseases, 77, 1558-1565. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Martinon, F., Burns, K. and Tschopp, J. (2002) The In-flammasome: A Molecular Platform Triggering Activation of Inflammatory Caspases and Processing of proIL-beta. Mo-lecular Cell, 10, 417-426. [Google Scholar] [CrossRef]
|
|
[6]
|
Masters, S.L., Simon, A., Aksentijevich, I., et al. (2009) Horror Autoinflammaticus: The Molecular Pathophysiology of Autoinflammatory Disease. Annual Review of Immunolo-gy, 27, 621-668. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Martinez-Quiles, N. and Goldbach-Mansky, R. (2018) Updates on Autoinflammatory Diseases. Current Opinion in Immunology, 55, 97-105. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Havnaer, A. and Han, G. (2019) Autoinflammatory Disorders: A Review and Update on Pathogenesis and Treatment. American Journal of Clinical Dermatology, 20, 539-564. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Yang, C.A. and Chiang, B.L. (2021) Inflammasomes and Childhood Autoimmune Diseases: A Review of Current Knowledge. Clinical Reviews in Allergy & Immunology, 61, 156-170. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Tangye, S.G., Al-Herz, W., Bousfiha, A., et al. (2022) Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee. Journal of Clinical Immunology, 42, 1473-1507. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Tangye, S.G., Al-Herz, W., Bousfiha, A., et al. (2020) Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee. Journal of Clinical Immunology, 40, 24-64. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Sprenkeler, E.G.G., Webbers, S.D.S. and Kuijpers, T.W. (2021) When Actin Is Not Actin’ Like It Should: A New Category of Distinct Primary Immunodeficiency Disorders. Journal of Innate Immunity, 13, 3-25. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Steiner, A., Harapas, C.R., Masters, S.L., et al. (2018) An Update on Au-toinflammatory Diseases: Relopathies. Current Rheumatology Reports, 20, 39. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Di Donato, G., D’angelo, D.M., Breda, L., et al. (2021) Mono-genic Autoinflammatory Diseases: State of the Art and Future Perspectives. International Journal of Molecular Sciences, 22, 6360. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
中华医学会儿科学分会风湿病学组, 中国医师协会风湿免疫科医师分会儿科学组, 海峡两岸医药卫生交流协会风湿免疫病学专业委员会儿童学组, 等. 儿童自身炎症性疾病诊断与治疗专家共识[J]. 中华实用儿科临床杂志, 2022, 37(3): 161-172.
|
|
[16]
|
Ter Haar, N.M., Oswald, M., Jeyaratnam, J., et al. (2015) Recommendations for the Management of Autoinflammatory Diseases. Annals of Rheumatic Diseases, 74, 1636-1644. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Demir, F., Gürler, E. and Sözeri, B. (2022) Efficacy of Anakinra Treatment in Pediatric Rheumatic Diseases: Our Single-Center Experience. Archives of Rheumatology, 37, 435-443. [Google Scholar] [CrossRef]
|
|
[18]
|
Li, W., Wang, W., Wang, W., et al. (2022) Janus Kinase Inhibitors in the Treatment of Type I Interferonopathies: A Case Series from a Single Center in China. Frontiers in Immunology, 13, Article ID: 825367. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Du, Y., Liu, M., Nigrovic, P.A., et al. (2023) Biologics and JAK Inhibitors for the Treatment of Monogenic Systemic Autoinflammatory Diseases in Children. Journal of Allergy and Clinical Immunology, 151, 607-618. [Google Scholar] [CrossRef] [PubMed]
|